Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Advanced Solid and Hematological TP53wt Tumors × siremadlin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 4 Neoplasm Metastasis 2 Colorectal Neoplasms 2 Uveal Melanoma 1 Triple Negative Breast Neoplasms 1 Sarcoma 1 Neoplasm, Residual 1 Liposarcoma 1 Hematologic Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Advanced Solid and Hematological TP53wt Tumors 1 Adenocarcinoma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02143635 2021-05-21

Study to Determine and Evaluate a Safe and Tolerated Dose of HDM201 in Patients With Selected Advanced Tumors That Are TP53wt

Novartis

Phase 1 Completed

Advanced Solid and Hematological TP53wt Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡